J&J Says Ultram Titration Schedule Was Developed To Improve Safety Profile
Executive Summary
A titration dosing regimen for Johnson & Johnson's analgesic Ultram was added to the non-titrated dosing schedule in labeling in order to reduce adverse events, J&J told FDA